Navigation Links
Leading Alzheimer's Disease Researcher Mark A. Smith, PhD Named Scientific Advisor at Advana Science
Date:5/21/2009

KIRKLAND, Wash., May 21 /PRNewswire/ -- Advana Science (www.advanascience.com) announced that Mark A. Smith, PhD, a leading researcher in Alzheimer's disease, has been named scientific advisor to the Company. According to the Journal of Alzheimer's Disease (Volume 16, Issue 3), Dr. Smith was ranked third in the world among the Top 100 Alzheimer's disease investigators in March 2009. Dr. Smith brings over 20 years of research experience focused on investigating the pathological mechanisms underlying selective neuronal death in neurodegenerative diseases such as Alzheimer's disease and is the executive director of the American Aging Association. As a professor at Case Western Reserve University since 1992, Dr. Smith also serves as the director of Basic Science Research of the University's Memory and Cognition Center.

"Advana Science is delivering on the ideal of advanced preventative and natural therapeutics derived from the latest scientific research," explained Dr. Smith. "The high quality amyloid research available to Advana Science is important because it offers safe, consumer access to natural-based applications available through nutraceutical and functional food products."

According to the 2009 Alzheimer's Disease Facts and Figures from the Alzheimer's Association:

  • Every 70 seconds, someone develops Alzheimer's.
  • As many as 5.3 million people in the United States are living with Alzheimer's.
  • Alzheimer's is the seventh-leading cause of death.
  • The direct and indirect costs of Alzheimer's and other dementias to Medicare, Medicaid and businesses amount to more than $148 billion each year.

Pharmaceutical drugs currently approved specifically to treat Alzheimer symptoms all ac
'/>"/>

SOURCE Advana Science
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Mosaica Partners Briefing Paper Identifies Leading Practices for States and Regions to Leverage ARRA Stimulus Funds for HIE
2. Leading US Pediatric Hospital Draws First Dose with RIVA System
3. Vivisimo Powers Site Search on Bupas Leading Health Information Websites Worldwide
4. Leading NGOs call for international action to combat epidemic of noncommunicable diseases
5. Leading Healthcare Technology Companies Launch National Physician Education Program on Stimulus and Electronic Health Records
6. Cynosure Enhances Industry-Leading Smartlipo Laser Lipolysis Workstation with Increased Energy and Intelligent Temperature Sensing
7. Quigley Corporation Receives Support from Leading Independent Proxy Advisory Firms; RiskMetrics and Glass Lewis Reject Dissident Stockholder Ted Karkus, Citing Failure to Provide Detailed Business Plan
8. Leading Italian Pharmaceutical Group Deploys TrackWise(R) Solution to Improve Quality Processes
9. iCardiac's Highly Automated QT(sm) Technology Cross-Validated Against Results from Five Leading ECG Core Laboratories
10. MedAptus Charge Capture Technology Deployed at Leading Manhattan Cardiovascular Practice
11. Video: Research in Womens Cancers Leading the Personalized Medicine Revolution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... Thanks to a $7.5 million grant from ... institutions, including American University, will operate in a new ... behavioral research aimed at ending the AIDS epidemic. , ... HIV or AIDS, according to the latest statistics. At ... over the age of 13 was living with HIV, ...
(Date:4/27/2015)... April 27, 2015 Guided by the ... of patient experience and its collaboration with organizations around ... Beryl Institute identifies eight essential actions for ... Beryl Institute believes organizations and systems committed to providing ... Identify and support accountable leadership with committed time and ...
(Date:4/27/2015)... A' Design Award and Competition is pleased to ... Boombang Inc Design Team has been announced as a ... Instruments, Medical Devices and Research Equipment Design Competition ... Inc Design Team, the creative team behind the awarded ... Lumica is a two-way communication device between patients and ...
(Date:4/27/2015)... Chicago and its seven surrounding counties have more ... communities healthier, more sustainable and more beautiful. Yet Chicago-area ... parkway trees likely to soon be destroyed by the ... “tipping point,” Chicago-area residents are concerned, as evidenced by ... . The Lisle, Illinois-based tree-focused institution’s Talking Trees survey ...
(Date:4/27/2015)... (PRWEB) April 27, 2015 Volpara ... 3.1 here at the Society of Breast Imaging’s ... 25-28, 2015 (SBI Booth #214). VolparaDensity, the ... use with digital breast tomosynthesis datasets from multiple ... the United States and worldwide. , ...
Breaking Medicine News(10 mins):Health News:D.C. Center for AIDS Research Established with New Grant from NIH 2Health News:D.C. Center for AIDS Research Established with New Grant from NIH 3Health News:Guiding Principles for Patient Experience Excellence Identified by The Beryl Institute 2Health News:Boombang Inc Design Team wins Platinum in A' Medical Product Design Awards 2Health News:New Study from The Morton Arboretum Reveals Chicagoans' Take on Trees 2Health News:New Study from The Morton Arboretum Reveals Chicagoans' Take on Trees 3Health News:New Study from The Morton Arboretum Reveals Chicagoans' Take on Trees 4Health News:Volpara Solutions Releases VolparaDensity 3.1 for Use with Tomosynthesis Systems from Multiple Manufacturers at SBI 2Health News:Volpara Solutions Releases VolparaDensity 3.1 for Use with Tomosynthesis Systems from Multiple Manufacturers at SBI 3
... claims that women who work nightshifts are more prone to ... women who regularly worked during the nights for up to ... than those who did not work at night. ,And the ... for more than three years. ,The results of ...
... Food and Drug Administration (FDA) has approved a contraceptive skin ... Johnson & Johnson, is a one-and-three-quarter-inch patch containing the hormones ... birth control pills. // ,The patch delivers the ... can be worn on the lower abdomen, buttocks or upper ...
... Inc. said it has received approval from the US ... agent Viread (tenofovir disoproxil fumarate) for the treatment of ... Viread, such drugs work by blocking the process needed ... the first nucleotide analogue reverse transcriptase inhibitor to be ...
... a group of older people in order to show- how eating ... group of 300 people aged 60 or over living in many ... or dark-skinned, those who ate lots of green leafy vegetables, beans, ... Eating less butter, red meat and sugar was also linked to ...
... according to Japanese research. ,It is thought that an ... the hardening of the arteries which could lessen blood ... there are other factors linked to moderate alcohol consumption ... researchers, at the National Institute for Longevity Sciences in ...
... of mouthwash is being hailed as a new weapon against ... some deodorants, seems to be able to prevent the growth ... of mosquitoes which causes as many as 3.2m deaths worldwide ... the agent has yet to be fully developed, the increasing ...
Cached Medicine News:
(Date:4/27/2015)... -- Bronstein, Gewirtz & Grossman, LLC is investigating potential ... Celladon Corporation ("Celladon" or the "Company") (NasdaqGM: CLDN -News).  ... or his investor relations coordinator Eitan Kimelman ... The investigation concerns whether Celladon and certain of its ... of the Securities Exchange Act of 1934.  ...
(Date:4/27/2015)... , April 27, 2015 Kalorama Information ... medical records (EMR) to grow well past the ... providers, according to a recent report.  The healthcare ... sales and continued efficiency improvements will grow the ... the next five years.  The market for EMR ...
(Date:4/27/2015)... BRH Medical, Ltd., today announced that it ... (510k) with the US Food and Drug Administration (FDA) ... feedback from the FDA during the next quarter and ... pre-market clearance. Additional pre-market regulatory filings are anticipated during ... BRH Medical, commented, "We are thrilled to have reached ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Celladon Corporation 2Kalorama: EMR Market Expected To Grow Beyond Incentives 2Kalorama: EMR Market Expected To Grow Beyond Incentives 3BRH Medical, Ltd., Announces Filing of a Pre-Market Submission with the US Food and Drug Administration (FDA) for the BRH-A2 Tissue Management System 2
... WASHINGTON, Nov. 2 The owner and operator of ... guilty to defrauding the Medicare program, announced Assistant Attorney ... Attorney Tim Johnson of the Southern District of Texas ... of Health & Human Services (HHS). , Noel Wayne ...
... , BOSTON, Nov. 2 Schering-Plough Corporation (NYSE: ... ongoing Phase IIa study of narlaprevir (SCH 900518), its ... treatment-naive patients with chronic hepatitis C virus (HCV) genotype ... in which patients received a 4-week lead-in of PEGINTRON(R) ...
Cached Medicine Technology:Medical Equipment Company Owner Pleads Guilty to Fraud Scheme Involving Nutritional Supplies and "Arthritis Kits" 2Medical Equipment Company Owner Pleads Guilty to Fraud Scheme Involving Nutritional Supplies and "Arthritis Kits" 3Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH 900518), an Investigational, Once-Daily Protease Inhibitor for Hepatitis C 2Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH 900518), an Investigational, Once-Daily Protease Inhibitor for Hepatitis C 3Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH 900518), an Investigational, Once-Daily Protease Inhibitor for Hepatitis C 4Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH 900518), an Investigational, Once-Daily Protease Inhibitor for Hepatitis C 5Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH 900518), an Investigational, Once-Daily Protease Inhibitor for Hepatitis C 6Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH 900518), an Investigational, Once-Daily Protease Inhibitor for Hepatitis C 7Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH 900518), an Investigational, Once-Daily Protease Inhibitor for Hepatitis C 8
... Laparoscopic Instruments incorporate a layered design unique ... and monitored to prevent stray electrosurgical burns ... by insulation failure or capacitive coupling; a ... built into all AEM Instruments provides a ...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
... aspiration holes and additional electrode tip ... precise dissection with decreased risk of ... ,Flexible design options allow the ... and multiple tip designs. Optimize specific ...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
Medicine Products: